5-fluorouracil extravasation following port failure.
A case is presented of cytotoxic extravasation as a result of an implantable venous port being perforated by a standard Huber needle. A patient receiving 5-fluorouracil via a dual reservoir port, implanted within the left chest wall, presented with hemoserous discharge from the right needle entry site. The left chest wall was warm to touch, erythematous, and swollen. Subcutaneous infiltration was suspected, and the infusion was ceased. A venogram was performed demonstrating significant extravasation around the left reservoir only. On port removal, inspection showed the Huber needle had penetrated the base plate on the left side. It is recommended that this complication be added as a possible sequelae of central venous port use.
Nesti
S P
SP
Cancer Division of Royal Perth Hospital, Perth, Australia.
Kovac
R
R
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D018279:Carcinoma, Signet Ring Cell / Q000188:drug therapy*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004868:Equipment Failure; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013274:Stomach Neoplasms / Q000188:drug therapy*
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil